CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
127779-20-8 | 沙奎那韦; 沙喹那韦; N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[(叔丁基氨基)甲酰]八氢-2(1H)-异喹啉基]-2-羟基-1-苄基 | SaquiNavir; N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-butanediamide | C38H50N6O5 | 详情 | 供应商 | |
150378-17-9 | 茚地那韦; (1(1S,2R),5(S))-2,3,5-三脱氧-N-(2,3-二氢-2-羟基-1H-茚-1-基)-5-[2-[[(1,1-二甲基乙基)氨基]羰? | IndiNavir; (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide | C36H47N5O4 | 详情 | 供应商 | |
155213-67-5 | 利托那韦; N-[(2S,3S,5R)-3-羟基-5-[[(2S)-3-甲基-2-[[甲基-[(2-异丙基-1,3-噻唑-4-基)甲基]氨基甲酰]氨基]? | RitoNavir; 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5R)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenyl-hexan-2-yl]carbamate | C37H48N6O5S2 | 详情 | 供应商 | |
157810-81-6 | 硫酸茚地那韦; (1(1S,2R),5(S))-2,3,5-三脱氧-N-(2,3-二氢-2-羟基-1H-茚-1-基)-5-[2-[[(1,1-二甲基乙基)氨基 | IndiNavir sulfate; (1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide sulfate | C36H47N5O4.H2SO4 | 详情 | 供应商 | |
159989-65-8 | 甲磺酸奈非那韦; 2-[(2R,3R)-2-羟基-3-[(3-羟基-2-甲基苯甲酰)氨基]-4-(苯基硫)丁基]-(3S,4aS,8aS)-N-叔丁基 | NelfiNavir mesylate; (3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide mesylate | C32H45N3O4S.CH4O3S | 详情 | 供应商 | |
174484-41-4 | 替拉那韦; N-[3-[(1R)-1-[(6R)-2-羟基-4-氧代-6-苯乙基-6-丙基-5H-吡喃-3-基]丙基]苯基]-5-(三氟甲基)吡啶-2 | TipraNavir; N-[3-[(1R)-1-[(6R)-2-Hydroxy-4-oxo-6-phenethyl-6-propyl-5H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide | C31H33F3N2O5S | 详情 | 供应商 | |
192725-17-0 | 洛匹那韦; (2S)-N-[(2R,4S,5S)-5-[[2-(2,6-二甲基苯氧基)乙酰]氨基]-4-羟基-1,6-二苯基-己-2-基]-3-甲基-2-( | LopiNavir; (2S)-N-[(2R,4S,5S)-5-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenyl-hexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide | C37H48N4O5 | 详情 | 供应商 | |
198904-31-3 | 阿扎那韦 | AtazaNavir; Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamat | C38H52N6O7 | 详情 | 供应商 | |
206361-99-1 | 地瑞那韦; 地瑞纳韦; 地瑞拉韦 | DaruNavir; [(3R,3aS,6aR)-2,3,3a,4,5,6a-Hexahydrofuro[5,4-b]furan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate | C27H37N3O7S | 详情 | 供应商 | |
226700-81-8 | 福沙那伟钙; 夫沙那韦钙; [(3S)-氧杂环戊-3-基]N-[(2S,3R)-4-[(4-氨基苯基)磺酰-(2-甲基丙基)氨基]-1-苯基-3- | FosampreNavir calcium; Calcium [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonatooxy-butan-2-yl]carbamate | C25H34CaN3O9PS | 详情 | 供应商 | |
229975-97-7 | 阿扎那韦硫酸盐 | AtazaNavir sulfate; Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamat | C38H52N6O7.H2SO4 | 详情 | 供应商 | |
161814-49-9 | 安普那韦 | AmpreNavir; Carbamicacid,[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-,(3S)-tetrahydro-3-furanyl ester (9CI); Carbamic acid,[3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-,tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2S*)]]-; 141W94; Agenerase; Angenerase; KVX 478; Prozei; SampreNavir; VX 478; | C25H35N3O6S | 详情 | 供应商 | |
226700-79-4 | FosampreNavir; Carbamicacid,[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-,C-[(3S)-tetrahydro-3-furanyl] ester (9CI); AmpreNavir phosphate; Carbamic acid,N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-,C-[(3S)-tetrahydro-3-furanyl] ester; Telzir; | C25H36N3O9PS | 详情 | 供应商 | ||
198904-87-9 | 阿扎那韦中间体 | Des-N-(methoxycarbonyl)-L-tert-leucine AtazaNavir Trihydrochloride; (aS,S)--Amino-a-[[1-[[4-(2-pyridinyl)phenyl]methyl]hydrazino]methyl]benzenepropanol Trihydrochloride; [S-(R*,R*)]--Amino-a-[[1-[[4-(2-pyridinyl)phenyl]methyl]hydrazino]methyl]benzenepropanol Trihydrochloride; Des-N-(methoxycarbonyl)-L-tert-leucine AtazaNavir Trihydrochloride; Intermediate of AtazaNavir | C22H29Cl3N4O | 详情 | 供应商 | |
198904-86-8 | Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc AtazaNavir; 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl] -2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylic Acid 1,1-Dimethylethyl Ester; Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc AtazaNavir; dimethylethoxy)carbonyl]amino]-2-hydroxy-4-; Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-; phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-,1,1-dimethylethyl ester; Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl ester | 无 | C32H42N4O5 | 详情 | 供应商 | |
176655-55-3 | DESTHIAZOLYLMETHYLOXYCARBONYL RITONavir | 无 | C32H45N5O3S | 详情 | 供应商 | |
185897-02-3 | IndiNavir-D-6; IndiNavir-D-6; 2,3,5-Trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl-d6)-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide | C36H41D6N5O4 | 详情 | 供应商 | ||
192725-39-6 | LopiNavir Metabolite M-1; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-d; LopiNavir Metabolite M-1; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami- de; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-a-(1-methylethyl)-2,4-dioxo-1(2H)-Pyrimidineacetami-de | C37H46N4O6 | 详情 | 供应商 | ||
221553-72-6 | LopiNavir Metabolite M-3/M-4; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-a-(1-methylethyl)-2-oxo-1(2H)-Pyrimidine-acetamid; LopiNavir Metabolite M-3/M-4; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-α-(1-methylethyl)-2-oxo-1(2H)-Pyrimidine-acetamide; (aS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-a-(1-methylethyl)-2-oxo-1(2H)-Pyrimidine-acetamide | C37H48N4O6 | 详情 | 供应商 | ||
947408-14-2 | TipraNavir Glucuronide; (2R)-3,6-Dihydro-6-oxo-2-(2-phenylethyl)-2-propyl-5-[(1R)-1-[3-[[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]amino]phenyl]propyl]-2H-pyran-4-yl -D-Glucopyranosiduronic Acid; TipraNavir -D-Glucuronide; TipraNavir Glucuronide | 无 | C37H41F3N2O11S | 详情 | 供应商 |